Finance

Lists
507789:BOM
Jagsonpal Pharmaceuticals Ltd
₹227.55
-1.26%
(-2.90) 1D
Aug 3, 2:29:53 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 507789...
Open
₹228.00
High
₹230.40
Low
₹227.55
Mkt. cap
14.98B
Avg. vol.
33.87K
Volume
8.01K
Dividend
1.76%
Quarterly dividend
₹1.00
Ex-dividend date
Sep 4, 2026
P/E ratio
33.91
52-wk high
₹282.95
52-wk low
₹154.90
EPS
₹6.71
Shares outstanding
26.20M
No. of employees
1K
Open
₹228.00
High
₹230.40
Low
₹227.55
Mkt. cap
14.98B
Avg. vol.
33.87K
Volume
8.01K
Dividend
1.76%
Quarterly dividend
₹1.00
Ex-dividend date
Sep 4, 2026
P/E ratio
33.91
52-wk high
₹282.95
52-wk low
₹154.90
EPS
₹6.71
Shares outstanding
26.20M
No. of employees
1K
News stories
From sources across the web
About Jagsonpal Pharmaceuticals Ltd
CEO-
Employees1.4K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websitejagsonpal.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
744.65M
729.45M
642.03M
822.32M
Cost of goods sold
272.28M
264.53M
237.67M
286.24M
Cost of revenue
272.28M
264.53M
237.67M
286.24M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
165.46M
172.95M
155.45M
227.78M
Operating expense
331.89M
326.10M
315.96M
385.10M
Total operating expenses
604.17M
590.63M
553.63M
671.34M
Operating income
140.48M
138.82M
88.40M
150.98M
Other non operating income
30.27M
29.75M
31.68M
28.33M
EBT including unusual items
168.10M
145.21M
117.56M
176.80M
EBT excluding unusual items
168.10M
166.00M
117.56M
176.80M
Income tax expense
42.36M
35.70M
29.94M
44.91M
Effective tax rate
25.20%
24.59%
25.47%
25.40%
Other operating expenses
126.28M
126.45M
137.32M
135.90M
Net income
125.74M
109.51M
87.62M
131.89M
Net profit margin
16.89%
15.01%
13.65%
16.04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.65M
-2.57M
-2.52M
-2.51M
Net interest expenses
-2.65M
-2.57M
-2.52M
-2.51M
Depreciation and amortization charges
23.86M
23.86M
23.19M
21.42M
EBITDA
164.18M
155.55M
112.01M
174.59M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps